Rockwell Medical (RMTI) Amortization of Deferred Charges (2016 - 2025)
Rockwell Medical's Amortization of Deferred Charges history spans 10 years, with the latest figure at $89000.0 for Q4 2025.
- For Q4 2025, Amortization of Deferred Charges changed 0.0% year-over-year to $89000.0; the TTM value through Dec 2025 reached $354000.0, down 16.9%, while the annual FY2025 figure was $354000.0, 16.9% down from the prior year.
- Amortization of Deferred Charges reached $89000.0 in Q4 2025 per RMTI's latest filing, roughly flat from $89000.0 in the prior quarter.
- In the past five years, Amortization of Deferred Charges ranged from a high of $831000.0 in Q4 2023 to a low of $30000.0 in Q2 2024.
- Average Amortization of Deferred Charges over 5 years is $131250.0, with a median of $92000.0 recorded in 2021.
- Peak YoY movement for Amortization of Deferred Charges: surged 793.55% in 2023, then crashed 89.29% in 2024.
- A 5-year view of Amortization of Deferred Charges shows it stood at $93000.0 in 2021, then changed by 0.0% to $93000.0 in 2022, then soared by 793.55% to $831000.0 in 2023, then plummeted by 89.29% to $89000.0 in 2024, then changed by 0.0% to $89000.0 in 2025.
- Per Business Quant, the three most recent readings for RMTI's Amortization of Deferred Charges are $89000.0 (Q4 2025), $89000.0 (Q3 2025), and $88000.0 (Q2 2025).